AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the expansion of its flagship processing facility in Alameda, California.
Amcor Unveils State-of-the-art Healthcare Packaging Facility In Singapore To Serve Accelerating Customer Demands In Asia Pacific
Sartorius will expand its capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy and Lourdes in order to meet the strong demand of the biopharmaceutical industry
Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides.
GE Healthcare Life Sciences and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy.
VetStem Biopharma, a veterinary and human regenerative medicine CRO, used its extensive experience, FDA master files, and database of veterinary stem cell therapy to secure FDA approval of a human IND for stem cell therapy in patients with osteoarthritis. VetStem made the application to FDA on behalf of its subsidiary, Personalized Stem Cells, Inc.
Hubbell Lighting is elevating the lighting experience. Empowered by lighting solutions that integrate seamlessly into their environment, save energy, provide improved quality of light, deliver return on investment and armed with Hubbell’s unflinching support, its customers are able to think differently about how, where, and when they can use light.
Mile High Labs, a Colorado startup that calls itself the world’s largest manufacturer of products, purchased the plant in Broomfield, Colorado, for about $18.8 million.
Multinational pharmaceutical company GlaxoSmithKlyne (GSK) launched two new pharmaceutical manufacturing facilities and an expanded production building at its Jurong site. According to GSK, the new and expanded sites will allow the faster production of drugs and Active Pharmaceutical Ingredients (APIs) for clinical trials.
The first attempts have launched to bio-engineer protein biomaterials like those found in mussels and tree frogs to yield similar amazing wet adhesion in sealants, coatings, glues, and medical adhesives. Crucial proteins in these animals exhibit unique behaviors and chemical reactivity, and the NYU Tandon School of Engineering researchers are creating hydrogels that borrow certain key features of those proteins: the separation of a solution into two distinct liquids in response to external stimuli, the incorporation of nonstandard amino acids, and patterning, such as the polygonal pillars seen in the toe pads of tree frogs.
CU Boulder researchers have developed nanobio-hybrid organisms capable of using airborne carbon dioxide and nitrogen to produce a variety of plastics and fuels, a promising first step toward low-cost carbon sequestration and eco-friendly manufacturing for chemicals.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems.